IL1RL1 and familial dilated cardiomyopathy: However, in both subgroups, a marked decrease in the biomarkers NT-proBNP and ST2 and also the body weight could be demonstrated, depicting an overall benefit of positive inotropic therapy for both ICM and DCM.